|
Nine Months Ended
|
||||||||
|
July 28,
2024
|
July 30,
2023
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
143,623
|
$
|
136,478
|
||||
|
Adjustments to reconcile net income to net cash
|
||||||||
|
provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
61,613
|
59,523
|
||||||
|
Share-based compensation
|
9,841
|
5,874
|
||||||
|
Changes in operating assets, liabilities and other
|
(22,003
|
)
|
(6,319
|
)
|
||||
|
Net cash provided by operating activities
|
193,074
|
195,556
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Purchases of property, plant and equipment
|
(87,733
|
)
|
(78,813
|
)
|
||||
|
Purchases of short-term investments
|
(100,558
|
)
|
(9,837
|
)
|
||||
|
Proceeds from maturities of short-term investments
|
44,696
|
22,500
|
||||||
|
Government incentives
|
1,541
|
2,033
|
||||||
|
Other
|
(4
|
)
|
(116
|
)
|
||||
|
Net cash used in investing activities
|
(142,058
|
)
|
(64,233
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Repayments of debt
|
(4,500
|
)
|
(16,351
|
)
|
||||
|
Proceeds from share-based arrangements
|
1,074
|
1,241
|
||||||
|
Net settlements of restricted stock awards
|
(3,002
|
)
|
(1,292
|
)
|
||||
|
Net cash used in financing activities
|
(6,428
|
)
|
(16,402
|
)
|
||||
|
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
|
(6,454
|
)
|
13,813
|
|||||
|
Net increase in cash, cash equivalents, and restricted cash
|
38,134
|
128,734
|
||||||
|
Cash, cash equivalents, and restricted cash, beginning of period
|
501,867
|
322,409
|
||||||
|
Cash, cash equivalents, and restricted cash, end of period
|
$
|
540,001
|
$
|
451,143
|
||||